West Pharmaceutical Services Inc (WST) Stock Forecast & Price Target
West Pharmaceutical Services Inc · NYSE
$337.08+5.83 (+1.76%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 10 firms covering West Pharmaceutical Services Inc, 9 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $311.00 to $447.00, a moderate spread. The average target of $376.44 sits 12% above the current $337.08. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 5 to 9 over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.27 next quarter toward $9.88 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 ratings
Moderate Buy
Strong Buy00%
Buy990%
Hold110%
Sell00%
Strong Sell00%
Based on 10 analysts giving stock ratings to West Pharmaceutical Services Inc.
As of Jul, 9 of 10 firms rate WST a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
WST EPS & revenue forecast
EPS · NEXT QUARTER
$2.27
Range $2.19 – $2.32 · 11 analysts · +11% YoY
Next period, 11 analysts expect West Pharmaceutical Services Inc to earn $2.27 a share (range $2.19 – $2.32), versus $2.04 a year earlier. Full-year consensus is $8.91, growing to $9.88 the year after.
REVENUE · NEXT QUARTER
$827.8M
Range $821.0M – $841.2M · 11 analysts · +3% YoY
Revenue is expected to reach $827.8M (range $821.0M – $841.2M), +2.8% year-over-year. Full-year consensus is $3.4B, rising to $3.6B next year.
Top analysts covering West Pharmaceutical Services Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on WST.
#1
Luke Sergott
Barclays · Rank #194
Buy
$400.00+18.7% to target
Overall win rate
41%
+ Follow
#2
Patrick Donnelly
Citigroup · Rank #260
Buy
$400.00+18.7% to target
Overall win rate
32%
+ Follow
#3
Paul Knight
Keybanc · Rank #296
Buy
$390.00+15.7% to target
Overall win rate
32%
+ Follow
#4
KT
Kallum Titchmarsh
Morgan Stanley
Hold
$365.00+8.3% to target
Coverage
—
+ Follow
#5
DM
Daniel Markowitz
Evercore ISI Group
Buy
$410.00+21.6% to target
Coverage
—
+ Follow
WST stock forecast FAQ
What is WST's average 12-month price target?+
The 9 analysts with a live target average $376.44 for West Pharmaceutical Services Inc over the next 12 months, ranging from a $447.00 high to a $311.00 low.
Is WST stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 10 analyst ratings, 9 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for WST?+
The Street-high target is $447.00 (BNP Paribas), and the Street-low is $311.00 (Rothschild & Co). The average of all 9 active targets is $376.44.
How many Wall Street analysts cover WST?+
10 analysts have an active rating on West Pharmaceutical Services Inc, and 9 firms carry a live 12-month price target.
Who is the most accurate analyst covering WST?+
Among analysts who currently cover WST, Luke Sergott of Barclays has the strongest overall Quantellect track record (Rank #194). Their current call is Buy with a $400.00 target.
What is West Pharmaceutical Services Inc's projected EPS for next quarter?+
The consensus estimate is $2.27 per share (range $2.19 – $2.32) across 11 analysts. Full-year EPS is projected at $8.91, rising to $9.88 the following year.
How much revenue is West Pharmaceutical Services Inc expected to report next quarter?+
Consensus revenue is $827.8M (range $821.0M – $841.2M). Full-year revenue is projected at $3.4B, growing to $3.6B next year.
Have analysts been upgrading or downgrading WST lately?+
As of Jul, 9 of 10 firms rate WST a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their WST calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
BNP Paribas
